Long Term Open Follow-up With H376/95 vs. Warfarin
NCT00206063 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2010-11-15
Summary
The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.
Conditions
- Stroke Prevention in Patients With Atrial Fibrillation
Interventions
- DRUG
-
EXANTA
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-08-31
- Primary Completion
- 2004-06-30
- Completion
- 2006-04-30
Countries
- United States
- Belgium
- Czechia
- Denmark
- Finland
- Norway
- Poland
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
NCT00633893 ·Status: COMPLETED ·Phase: PHASE3
-
Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment
NCT01721837 ·Status: COMPLETED
-
Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
NCT00742859 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
NCT02164864 ·Status: COMPLETED ·Phase: PHASE3
-
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region
NCT01800006 ·Status: COMPLETED
-
Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants
NCT03742336 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
NCT02149303 ·Status: COMPLETED
-
A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
NCT03792152 ·Status: UNKNOWN ·Phase: NA
-
Secondary Prevention of Venous Thrombo Embolism (VTE).
NCT00329238 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy
NCT02836652 ·Status: COMPLETED ·Phase: PHASE4
-
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
NCT00056550 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)
NCT00680186 ·Status: COMPLETED ·Phase: PHASE3
-
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
NCT00808067 ·Status: COMPLETED ·Phase: PHASE3
-
Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon
NCT02591225 ·Status: UNKNOWN ·Phase: PHASE4
-
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 ·Status: COMPLETED ·Phase: PHASE2
-
Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
NCT02556203 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
NCT03666962 ·Status: UNKNOWN
-
Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention
NCT00818753 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
NCT04249401 ·Status: COMPLETED
-
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
NCT02210819 ·Status: COMPLETED
-
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
NCT01547728 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
NCT04502017 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
NCT01619007 ·Status: COMPLETED